High-Flow Nasal Oxygen and Noninvasive Ventilation for COVID-19.
Crit Care Clin
; 38(3): 601-621, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1850766
ABSTRACT
High-flow nasal oxygen (HFNO) and noninvasive ventilation (NIV) via facemask or helmet have been increasingly used in managing acute hypoxemic respiratory failure (AHRF) owing to COVID-19 with the premise of reducing the need for invasive mechanical ventilation and possibly mortality. Their use carries the risk of delaying intubation and nosocomial infection transmission. To date, most studies on the effectiveness of these modalities are observational and suggest that HFNO and NIV have a role in the management of AHRF owing to COVID-19. Trials are ongoing and are evaluating different aspects of noninvasive respiratory support in patients with AHRF owing to COVID-19.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Insuficiencia Respiratoria
/
Ventilación no Invasiva
/
COVID-19
Tipo de estudio:
Estudio experimental
/
Estudio observacional
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Crit Care Clin
Asunto de la revista:
Terapia intensiva
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
J.ccc.2022.01.006
Similares
MEDLINE
...
LILACS
LIS